Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Startect 10 mg Solution is a Health Canada–registered veterinary drug (DIN 02454327) held by Zoetis Canada Inc, containing Derquantel. Health Canada lists its status as Dormant (status date 19 Jul 2021). Nexara Health has matched 1 registration of Derquantel across 1 other regulated market.

Health Canada registration

DIN02454327
Brand nameStartect
Active ingredientDerquantel
Strength10 mg
Dosage formSolution
RouteOral
CompanyZoetis Canada Inc
StatusDormant — 19 Jul 2021
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Derquantel registered in other markets

1 registration of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
United StatesDerquantelPharmacia & Upjohn Company LLCPowderFDA NDC

See every manufacturer of Derquantel worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Startect (DIN 02454327) marketed in Canada?

No. Health Canada lists DIN 02454327 as Dormant as of 19 Jul 2021.

Who holds the Canadian licence for this product?

Zoetis Canada Inc is the company of record in the Health Canada Drug Product Database.

Is Derquantel registered outside Canada?

Yes — Nexara Health has matched 1 registration in 1 other market (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02454327, status date 2021-07-19; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02454327, status date 2021-07-19; national medicine registries: FDA NDC.

Health Canada Drug Product Database (DPD), DIN 02454327, status date 2021-07-19; national medicine registries: FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.